Keywords
Non-small cell lung cancer
Chemotherapy
Submitted : 2022-08-06
Accepted : 2022-08-21
Published : 2022-09-05
Abstract
Objective: To explore the value of circulating tumor cells in evaluating the effect of chemotherapy for advanced non-small cell lung cancer. Methods: Sixty-two patients with advanced non-small cell lung cancer who received chemotherapy in the Affiliated Hospital of Hebei University from January 2018 to December 2021 were selected as the research subjects. The positive rate of CTCs after two weeks of chemotherapy and four weeks of chemotherapy as well as the evaluation of imaging efficacy were observed and analyzed. Results: Based on the clinical data of the patients, the positive rate of CTCs in male patients was 77.78%, that in female patients was 80.77%, that in patients ? 60 years old was 78.13%, that in patients < 60 years old was 76.67%, that in squamous cell carcinoma was 79.31%, that in adenocarcinoma was 78.79%, and that in highly differentiated, moderately differentiated, and poorly differentiated + undifferentiated CTCs was 66.67%, 84.21%, and 90.91%, respectively; there was no statistical difference in the general data. The positive rate of CTCs was 88.71% before chemotherapy and 66.13% after two weeks of chemotherapy, in which the difference was statistically significant; the positive rate of CTCs four weeks after chemotherapy was 59.68%, which was statistically significant compared with that before chemotherapy; however, there was no significant difference between two weeks after chemotherapy and four weeks after chemotherapy. After chemotherapy, 35 patients had CR+PR, 19 patients had SD, and 8 patients had PD. The proportions of CR+PR, SD, and PD in the imaging evaluation results were 56.45%, 30.65%, and 12.90%, respectively. After kappa consistency test, it was found that the consistency was good. Conclusion: CTCs can be used as one of the indicators to evaluate the effect of chemotherapy for advanced non-small cell lung cancer. The results are consistent with those of imaging evaluation. The detection of CTCs can be widely used as one of the clinical indicators.
References
Lu B, Gao Y, Wang Q, et al., 2021, Clinical Significance of Detection of EpCAM Positive Circulating Tumor Cells in Peripheral Blood of Small Cell Lung Cancer. Modern Oncology, 29(19): 3400–3405.
Xu J, Wang J, Lin Y, et al., 2021, Feasibility and Application of Detecting Epidermal Growth Factor Receptor Mutations in Peripheral Blood of Patients with Advanced Non-Small Cell Lung Cancer with Small Volume Nucleic Acid Samples. Chinese Journal of Clinical Laboratory Management, 9(03): 164–168.
Luo Y, Cheng S, Chen W, 2021, Expression of High Mobility Group Protein A2 Glycochain Protein 125 in Circulating Tumor Cells and Its Relationship with Cellular Immune Function in Patients with Non-Small Cell Lung Cancer. Journal of Practical Medical Technology, 28(08): 1001–1004.
Jiang X, Lu J, Gu Y, et al., 2021, Association Between Circulating Tumor Cell Chromosome 7 and 8 Polysomes and Epidermal Growth Factor Receptor Gene Mutations in Patients with Non-Small Cell Lung Cancer. Chinese Journal of Pathology, 50(05): 447–452.
Lu X, 2021, Application of Circulating Tumor Cells in Diagnosis and Treatment of Small Cell Lung Cancer, dissertation, Beijing University of Traditional Chinese Medicine.
Paez JG, Janne PA, Lee JC, et al., 2004, EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy. Science, 304(5676): 1497–1500.
Du J, Xu X, Bian J, 2021, Preliminary Study on the Value of Peripheral Blood Circulating Tumor Cells in the Efficacy and Prognosis of Immunochemotherapy in Patients with Advanced Lung Squamous Cell Carcinoma. Chinese Journal of Modern Medicine, 23(03): 9–14.
Cao D, Wang H, 2021, Diagnostic Value of Circulating Tumor Cells, Carcinoembryonic Antigen and Imaging in Non-Small Cell Lung Cancer. Chinese Modern Doctor, 59(08): 46–49 + 193.
Mei J, Yan G, 2021, Study on the Levels of NSE, CEA and CYFRA21-1 in Peripheral Blood Circulating Tumor Cells of Patients with Lung Cancer. Marker Immunoassay and Clinical, 28(01): 37–40.
Lu X, Chen H, Ma S, et al., 2020, Analysis of the Predictive Value of Circulating Tumor Cells in the Chemotherapy Effect of Small Cell Lung Cancer. Journal of Clinical Laboratory, 38(11): 861–863.
Gao T, Huan G, Lian Y, et al., 2020, Application of Detection of Circulating Tumor Cells in Plasma of Patients with Non-Small Cell Lung Cancer in Chemotherapy. Shenzhen Journal of Integrated Traditional Chinese and Western Medicine, 30(21): 16–17.
Li A, He X, Shen Z, 2020, Relationship Between Peripheral Blood Circulating Tumor Cell Count and Prognosis in Patients with Advanced Non-Small Cell Lung Cancer Before and After Chemotherapy. Contemporary Medicine, 26(25): 126–127.
Liang Y, 2020, Relevant Study on the Correlation Between Circulating Tumor Cells and the Progression and Prognosis of Lung Cancer, dissertation, Southern Medical University.
Wu L, Qi M, Qi Z, 2020, Predictive Value of Peripheral Blood Circulating Tumor Cell Detection for Chemotherapy Effect in Patients with Non-Cell Lung Cancer. China Health Engineering, 19(01): 103–104.
Li J, Zhang C, Zhao W, et al., 2019, Research Application of Circulating Tumor Cells in Diagnosis and Treatment of Non-Small Cell Lung Cancer. Modern Medicine and Health, 35(20): 3114–3116.
Yan H, 2019, Research Application of Circulating Tumor Cell Detection in Diagnosis and Treatment of Non-Small Cell Lung Cancer, dissertation, Shanghai Jiaotong University.
Che K, Cha G, 2021, Clinical Application of Circulating Tumor Cells in the Evaluation of Chemotherapy Efficacy of Advanced Non-Small Cell Lung Cancer. Jiangxi Medicine, 56(12): 2351–2353 + 2369.
Chen X, Wang S, Cui X, 2019, Research Progress in Detection Methods and Clinical Application of Circulating Tumor Cells. Biomedical Engineering and Clinical, 23(06): 746–751.
Zhu Y, Zhang L, 2019, Application of Circulating Tumor Cell Detection in Chemotherapy of Non-Small Cell Lung Cancer. Journal of Clinical Lung, 24(05): 933–935.
Wang D, Yin L, Zhou M, et al., 2018, Application Analysis of Circulating Tumor Cell Detection in Predicting Chemotherapy Patients with Non-Small Cell Lung Cancer. Electronic Journal of Clinical Medical Literature, 5(69): 176.
Li F, Lu Y, Wang Y, et al., 2018, Application of Circulating Tumor Cell Detection in Evaluation of Chemotherapy Efficacy of Non-Small Cell Lung Cancer. International Journal of Respiration, 38(12): 898–903.